Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Gains from Equity Investments (2018 - 2023)

Updated

Analysis

Bristol Myers Squibb (BMY) Gains from Equity Investments (2018 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 58.00 Mn
Mar 31, 2023 155.00 Mn
Sep 30, 2022 14.00 Mn
Jun 30, 2022 308.00 Mn
Mar 31, 2022 644.00 Mn
Mar 31, 2020 339.00 Mn
Sep 30, 2019 261.00 Mn
Jun 30, 2019 -71.00 Mn
Mar 31, 2019 -175.00 Mn
Sep 30, 2018 -97.00 Mn
API Access

Bristol Myers Squibb Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=BMY&period=max&api_key=YOUR_API_KEY